abstract |
The present invention relates to a novel compound as a vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist, an isomer thereof or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition containing the same. The present invention relates to pain, migraine, joint pain, neuralgia, neuropathy, neuropathy, skin disease, urinary bladder hypersensitivity, irritable bowel syndrome, fecal urgency, respiratory disease, skin, eye or mucous membrane irritation, gastroduodenal ulcer The present invention provides a pharmaceutical composition for preventing or treating diseases such as inflammatory diseases, ear diseases, heart diseases and the like. [Selection figure] None |